About the Company
Filament Health Corp
BUSINESS DESCRIPTION
We honed our expertise at Mazza Innovation, a natural extraction startup, which our team scaled from pre-seed to an exit in 2018. At Mazza, we developed and commercialized patent-protected extraction technologies at a 35,000 ft2 commercial-scale GMP facility. ..
Filament Health Corp News
-
FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS AND OPERATIONAL H...
05/08/2025 10:26 PMFilament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, release...
-
FILAMENT HEALTH ANNOUNCES FDA AUTHORIZATION OF PHASE 2 CLINICAL TRIAL STUDYING P...
04/09/2025 11:00 AMFilament Health Corp. (OTCQB:FLHLF) (CBOE:FH) (FSE:7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today an...
-
Weekly Roundup on the Cannabis Sector & Psychedelic Sector...
04/07/2025 12:27 PMKey Takeaways; Cannabis Sector Advanced Flower injected $14 million to fuel Standard Wellness expansion across key U.S. markets Organigram expanded into U.S. he...
-
FILAMENT HEALTH ANNOUNCES PRIVATE PLACEMENT AND INTENTION TO VOLUNTARILY DELIST ...
04/03/2025 10:25 PMFilament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, to...
-
FILAMENT HEALTH REPORTS Q4 AND YEAR END 2024 FINANCIAL RESULTS AND OPERATIONAL H...
04/01/2025 09:00 PMFilament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, released...
-
FILAMENT HEALTH ANNOUNCES POSITIVE DATA FROM PHASE 2 STUDY OF PEX010 IN PATIENTS...
03/17/2025 11:00 AMFilament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today ...
-
FILAMENT HEALTH ANNOUNCES SHIPMENT OF BOTANICAL PSILOCYBIN TO THE UNIVERSITY OF ...
01/21/2025 12:00 PMFilament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, to...
-
FILAMENT HEALTH ANNOUNCES IMPORT OF COCA LEAF FROM PERU BY JOINT VENTURE MAGDALE...
12/16/2024 12:00 PMFilament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or "Filament Health"), a clinical-stage natural psychedelic drug development company, ...
-
FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL H...
11/15/2024 12:14 AMFilament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, rele...
Disclaimer: